Home / Prepare Your Business for Sale / Medical Spa

How to Prepare and Sell Your Med Spa in 2026: The Three-Year Medical Spa Exit Playbook

If you plan to sell your med spa, preparing it for exit in 2026 is a three-year playbook, not a decision made in the LOI. The first 12 months are about the value levers PE sponsors underwrite (recurring visit frequency, provider retention, injectables mix, real-estate structure), the middle 12 fix the deal-killers auditors will find, and the final 12 turn the process into a competitive one where multiple bidders decide your outcome.

Getting a med spa ready to sell means proving to a buyer that a business which feels like retail is, underneath, a properly run medical practice. Owners who start 12 to 36 months out can fix the ownership structure, the supervision paper trail, product sourcing and the books before anyone outside the company looks at them. This page covers those items in the order buyers test them.

Updated October 2026 · CT Acquisitions

The med spa owners who are disappointed by their first offer usually lose value in diligence, not in the headline price. A buyer sends an attractive letter of intent, then its lawyers find that the medical director has never seen a patient, that some toxin came from an unfamiliar supplier, or that prepaid packages were booked as revenue the day they were sold. Each finding becomes a price cut, a larger holdback or a walk-away. Preparation is the work of finding those problems yourself, early enough to fix them cheaply. The American Med Spa Association puts the medical aesthetics industry above $17 billion in revenue and growing by more than $1 billion a year, so buyers have plenty of targets to choose from and little patience for one that needs rebuilding.

This guide is written for owners of a single location or a small group who expect to sell to a private equity backed platform, a management services organization, or another operator in the next one to three years. It explains who buys, how they structure offers, what makes a med spa different from other service businesses in diligence, and a month-by-month calendar for getting ready. Where a rule is state specific, we name the state and the source so you can check how your own state handles it.

Why a Med Spa Is Diligenced Like a Medical Practice, Not a Salon

From the front desk, a med spa looks like a beauty business: memberships, gift cards, retail skincare, online booking and a loyal client base. To a buyer’s lawyers, it is a place where prescription drugs are injected, lasers are fired and medical judgment is exercised, usually by nurses and other providers working under a physician. That difference drives the entire preparation agenda.

Three consequences follow. First, who owns the business and who controls clinical decisions is a legal question in many states, not a matter of preference. Second, every treatment needs a supervision and delegation record that would satisfy a state medical or nursing board. Third, the products used on patients must come from sources that federal law accepts. A salon buyer does not care about any of these. A med spa buyer will spend more of its diligence budget on them than on the financial statements.

The good news is that each of these items is documentary. You can fix a structure, write a protocol, keep a log and change a supplier well before a sale. The owners who struggle are the ones who discover the gaps while a buyer’s deadline is running.

Who Buys Med Spas Today and How Offers Are Built

Most sellers in this sector end up talking to a platform: a group of clinics owned by a private equity sponsor, often run through a management services organization that provides back-office support to physician-owned practices. Some platforms buy the whole business; many prefer partnerships where the founder keeps a stake.

Platforms named in public sources

AmSpa’s review of 2025 deal activity named Empower Aesthetics (backed by Shore Capital), Alpha Aesthetics (Thurston Group), Advanced MedAesthetic Partners (Leon Capital) and Well Labs+ (Camino Partners, founded by Daniel Lubetzky) as likely recapitalization candidates for 2026 and 2027. A recapitalization at the platform level matters to you as a seller because founders who rolled equity into a platform typically see that stake valued, and sometimes partly cashed out, when the sponsor sells or brings in new capital.

Other platforms describe their model on their own websites. Princeton Medspa Partners lists James Waskovich, co-founder and managing partner of Princeton Equity Group, as its chairman, says it works with traditional med spas, cosmetic dermatology, plastic surgery and functional medicine clinics, and tells owners, “We’ll help you grow your aesthetic medical clinic, not run it.” Alpha Aesthetics Partners says it is backed by private equity and pitches founders on owning a stake in a larger group, arguing that “as Alpha grows, your equity position becomes more valuable (and less risky) than if you owned 100% of your practice.” In Canada, Persistence Capital Partners lists MedSpa Partners in its portfolio as “A better option for Canada’s leading medspas and dermatology clinics.”

Read those pitches carefully. Each one tells you what the buyer values: local brand continuity, a founder who stays involved, and clinics that can plug into shared purchasing and back-office systems. If your business already runs on documented processes and has more than one strong provider, you fit that template. If everything runs through you, the buyer is pricing a transition risk.

What a 60/40 offer means in practice

AmSpa reports that most med spa transactions in 2025 were structured with roughly 60% of the price in cash at closing and 40% as rollover equity or stock, with some deals reaching 80% cash and 20% rollover. The same review notes that holdbacks and earnouts stayed common, especially where provider transition or post-closing growth plans were central to the deal, and that buyers’ primary objective remained risk mitigation.

For a seller, that structure has three practical effects:

• Your cash at closing is smaller than the headline. If the letter of intent says a certain enterprise value and 40% is rollover, you are converting a large part of your sale into a minority stake in someone else’s company.
• The rollover is only as good as the platform. Before you accept equity, ask for the platform’s debt load, its growth plan, the rights attached to your units, and what happens to your stake if the sponsor sells.
• Earnouts and holdbacks attach to the things buyers fear. In med spa deals that usually means provider retention and post-closing revenue. The better your preparation on those points, the more of the price you can move into cash.

How buyers bucket med spas by size

AmSpa’s look-back summarized 2025 pricing in revenue bands: med spas under $4 million in revenue traded at about 3x to 6x EBITDA, reflecting owner reliance and continuity risk; businesses between $4 million and $20 million at about 5x to 8x; and those above $20 million at about 7x to 12x, with premium brands at the top of each band. The article’s summary line is the one to remember: “Buyers continue to pay for quality, not just topline growth.” The rest of this page is about the quality items that move a business from the bottom of its band toward the top.

Other buyer types

Platforms are not the only route. Dermatology and plastic surgery groups sometimes buy med spas that complement their cosmetic services, especially when the spa sits in a market they already serve. Individual buyers, often an experienced injector or a physician who wants to own a practice, are a realistic option for smaller single-location businesses, though they usually depend on bank financing and offer more modest prices. Some owners also sell a partial stake to a senior provider over time. Each route changes what you need to prepare: a physician buyer may simplify the ownership structure question, an individual buyer will need lender-ready financials, and a platform will run the fullest diligence of all. Decide early which routes you want to test so your preparation matches the buyers you will meet.

The Ownership Structure Test: Corporate Practice of Medicine

The first legal question in any med spa deal is whether the business is allowed to exist in its current form. Many states prohibit the corporate practice of medicine, meaning a company owned by non-physicians cannot provide medical services or control a physician’s clinical judgment. The usual workaround is a two-entity model: a professional corporation owned by a licensed physician provides the medical services, and a management services organization owned by the business founder or investors provides non-clinical support for a fee.

California as the reference point

California is the state buyers use as the strict benchmark, and AmSpa’s 2025 review notes that California drew extra scrutiny on scope of practice, injectable supervision and MSO structures. The Medical Board of California publishes a list of decisions that should be made by a California-licensed physician. On the clinical side these include choosing diagnostic tests, deciding on referrals and taking responsibility for the patient’s care. On the business side the Board lists ownership and control of patient medical records, hiring and firing of physicians, allied health staff and medical assistants as it relates to clinical competency, decisions on coding and billing, and approving the selection of medical equipment and supplies.

Look at that list as a buyer would. If your management company chooses which lasers to lease, hires and fires injectors, or owns the patient charts, a California buyer’s counsel will ask whether the physician entity has real control. Fixing it before a sale usually means rewriting the management services agreement so those decisions sit with the physician entity, and then operating that way for long enough that the records show it.

The paper medical director problem

The Board’s guidance includes an example that reads as if it were written for this industry: a spa offering Botox and laser hair removal that hires a physician as its medical director. The Board says that arrangement would involve non-physicians in the unlicensed practice of medicine and could expose the physician as an aider and abettor. It separately lists a physician serving as medical director for a practice the physician does not own as a prohibited structure. The Board also points to Business and Professions Code section 2417.5, which applies to businesses offering outpatient elective cosmetic medical procedures in violation of the corporate practice ban and ties that conduct to Penal Code section 550(a)(6) on false or fraudulent claims.

Many owners outside California assume a signed medical director agreement settles the question. In a strict state it does not. The question is who owns the medical entity and who is exercising medical judgment. If your current setup is a lay-owned company that pays a physician a monthly fee to lend a license, plan to restructure with healthcare counsel before you go to market.

What buyers read in your management services agreement

Assuming you already use a physician entity and a management company, buyers will read the agreement between them line by line. Expect questions on:

• How the management fee is set and whether it reflects the value of services provided, since fees based on a share of medical revenue raise fee-splitting concerns in some states.
• Whether the physician owner can be replaced, and how, because a buyer needs a way to keep the medical entity running if the physician leaves.
• Who holds the patient charts, the clinical protocols and the provider employment agreements.
• Whether the agreement and any stock transfer restrictions on the physician entity can be assigned to the buyer.

Other states: check, do not assume

Rules on ownership, delegation and supervision differ widely. Some states have little or no corporate practice restriction; others are stricter than California on who may inject or fire a laser. Ask healthcare counsel for a short written memo on your state’s position, and keep it in the data room. A buyer will commission the same analysis, and having yours ready shortens that part of diligence.

Supervision and Delegation: The Paper Trail Behind Every Treatment

A buyer will want to see who examined each patient, who authorized the treatment, who performed it and under what written protocol. That trail exists in some form at most med spas. The question is whether it is complete, consistent and stored where it can be produced.

Texas shows how quickly this area changes. House Bill 3749, known as Jenifer’s Law, was signed on June 20, 2025 and took effect on September 1, 2025, adding a chapter to the Texas Occupations Code that regulates elective intravenous therapy. According to the enrolled text, a physician may delegate prescribing or ordering of elective IV therapy to a physician assistant or advanced practice registered nurse, and administration to a physician assistant, advanced practice registered nurse or registered nurse, in each case acting under adequate physician supervision. A Texas med spa with an IV drip menu that predates the law should be able to show how its delegation and supervision arrangements were updated.

Items to assemble:

• Written delegation or standing order protocols for each treatment category you offer (neurotoxins, fillers, lasers and energy devices, microneedling, IV therapy, weight-loss prescribing).
• Evidence of the supervising physician’s involvement, such as chart review logs, meeting notes and sign-offs, at the frequency your state requires.
• Current licenses and any required certifications for every provider, with expiry dates, checked against your state boards’ online lookups.
• Good faith exam or initial assessment records for new patients, where your state requires them before a delegated treatment.
• An adverse event log with dates, follow-up and resolution, plus the informed consent forms used for each treatment.

Gaps here are common and fixable. What a buyer cannot accept is discovering them for the first time in its own review, because it then has to assume the problem is larger than it looks.

Product Sourcing: Why Buyers Audit Your Toxin Invoices

Neurotoxins and fillers are the core of most med spa revenue, and buyers now check where they came from. On April 16, 2024 the U.S. Food and Drug Administration warned that counterfeit Botox had been found in multiple states, and reminded health care professionals that federal law requires providers who dispense or administer prescription drugs to buy them only from authorized sources. The agency pointed providers to its Know Your Source resource for checking suppliers.

In diligence, that warning becomes a request for purchase records. A buyer may sample invoices for neurotoxins and fillers over the last few years and match them to the manufacturer or its authorized distributors. If purchases from unfamiliar suppliers at unusually low prices appear, expect hard questions, possible patient notification issues and, in the worst case, a buyer that will not proceed.

Preparation is simple but needs time. Move all purchasing to the manufacturers’ direct programs or authorized distributors now, keep every invoice, and make sure the records are tied to the lot numbers used in your charts. If there is history you are not comfortable with, discuss it with counsel well before a sale so it can be addressed on your terms.

Weight-Loss Programs and Compounded Drugs: Revenue a Buyer May Discount

Many med spas added medical weight-loss programs built on GLP-1 medications in recent years, some using compounded versions. Buyers look at this revenue differently from injectables or laser work. The FDA explains that compounders may prepare compounded versions of drugs that are on FDA’s drug shortages list when they meet certain conditions in federal law. When a drug’s shortage status changes, the legal basis for some compounded versions can change with it, and revenue that depended on those products may not continue in the same form.

What to prepare:

• A breakdown of weight-loss revenue by product type (branded versus compounded) and by month, so a buyer can see trends rather than a single total.
• The name and license status of each compounding pharmacy you use, and whether it operates as a traditional pharmacy or an outsourcing facility.
• Your prescribing protocol, including who examines patients, who prescribes and how follow-up is handled, checked against your state’s rules.
• Patient retention data for the program, since buyers want to know whether weight-loss patients also buy other services.

Be ready for a buyer to value this line at a lower multiple than your core aesthetic services, or to exclude it from the earnings it pays for if the supply basis is uncertain. Presenting it honestly and separately helps you defend the rest of the business.

Marketing, Reviews and Influencer Content Under FTC Rules

Med spas rely heavily on social media, before-and-after imagery, online reviews and creator partnerships. Federal rules on those channels have tightened, and buyers now review marketing as a compliance item.

The Federal Trade Commission updated its Endorsement Guides in 2023. Its guidance says material connections between a business and an endorser must be disclosed clearly and conspicuously, that “#ad” or “Ad:” at the start of a post is likely adequate, and that terms such as “#sponsored” alone, “#ambassador” or “Gifted” without the brand name may not be enough. The FTC also says advertisers remain responsible for what influencers claim and should train and monitor the people promoting them.

Reviews carry their own risk. On August 14, 2024 the FTC announced a final rule banning fake reviews and testimonials, paying for reviews that express a particular sentiment, undisclosed insider reviews and review suppression, and allowing the agency to seek civil penalties against knowing violators. A med spa that offered discounts for five-star reviews, or had staff post reviews without disclosure, should stop now and keep a record of the change.

Documents to assemble for the data room:

• Written agreements with every influencer or creator, with the disclosure language they were required to use.
• A log of paid posts with links, dates and screenshots showing the disclosure.
• Your review request process, showing that requests go to all patients without conditions on rating.
• Before-and-after image consents from patients.
• A breakdown of new patients by channel, so a buyer can see that demand does not rest only on the owner’s personal social following.

Providers, Non-Competes and the People Risk

In most med spas, patients are loyal to an injector first and a brand second. Buyers therefore look hard at whether the providers will stay and what stops them from leaving with their patients. AmSpa’s 2025 review links earnouts and holdbacks directly to provider transition, which tells you where buyers see the risk.

The legal tools for keeping providers vary by state. A federal ban will not settle the question: on September 5, 2025 the FTC voted 3-1 to dismiss its appeals and accede to the vacatur of its Non-Compete Clause Rule, leaving enforceability of non-competes to state law. Some states enforce reasonable restrictions on healthcare workers, others limit or prohibit them. Ask counsel what your state allows for nurses, physician assistants and nurse practitioners, and make sure every provider is on a written agreement that uses the tools available to you, such as non-solicitation of patients and staff, confidentiality and notice periods.

Agreements are only part of the answer. Buyers are more reassured by evidence that patients follow the clinic, not the person:

• Patient panels shared across providers, with records showing patients seen by more than one injector.
• Provider tenure and turnover data over several years.
• Compensation plans that reward staying, such as retention bonuses or a path to senior or lead roles.
• Correct employment classification for clinical staff, since providers paid as contractors while working under your protocols raise tax and supervision questions.
• A clear plan for the owner’s own clinical role after closing, if the owner is also a high-volume injector.

Operating Improvements Buyers Reward in a Med Spa

Compliance work protects the price. Operating work raises it. The items below are the ones buyers in this sector look at when deciding where in a valuation band a business belongs, and each takes a year or more to show up in the numbers, which is why they belong early in the calendar.

Membership design that holds up to scrutiny

A membership program helps only if members stay and use it. Buyers look past the member count to cancellation rates, how many banked credits go unused, and whether members spend more than non-members. A program with generous rollover of unused credits can look strong on sign-ups while building a large deferred revenue balance that a buyer will treat as debt. Design plans with clear expiry rules that your state allows, report member behavior monthly, and make sure the accounting matches the terms patients signed.

Pricing discipline

Discounting at the chair is one of the fastest ways to erode margin in an injectables business. Buyers ask whether providers can change prices, how often the price list is reviewed and how promotions are approved. Set prices centrally, record promotions as such rather than as provider discretion, and review the price list at least once a year. A record of steady pricing tells a buyer that revenue growth came from patients and visits rather than from a one-off campaign.

Provider capacity and scheduling

Buyers want to know whether the business can grow without hiring the owner’s replacement first. Report provider utilization from your booking system: booked hours against available hours, rebooking rates and no-show rates. Spare capacity with a waiting list is a growth story. Fully booked providers with no bench is a risk story.

A service mix that does not depend on one product

A business built almost entirely on neurotoxins is exposed to pricing and supply changes for a single product family. Adding fillers, skin treatments, energy-based devices and retail spreads that exposure and gives patients more reasons to return. Add services only where you can staff and supervise them properly, since each new category brings its own delegation and training requirements.

Management that is not the owner

Most buyers will ask who runs the clinic day to day. A practice manager with authority over scheduling, staffing, purchasing and reporting, in place for at least a year before the sale, changes the conversation from “what happens when the founder leaves” to “how fast can this grow.”

Patient Records and HIPAA in a Sale

Buyers need to review patient data during diligence and will take over the records at closing. Owners sometimes worry that sharing this information breaks privacy rules. The HIPAA Privacy Rule addresses the situation directly: the definition of health care operations in 45 CFR 164.501 includes the sale, transfer, merger or consolidation of all or part of a covered entity with another covered entity, or with an entity that will become one, and due diligence related to that activity.

That does not mean anything goes. Share the minimum necessary, use de-identified or summarized data in the early rounds, and save chart-level access for the confirmatory stage under a signed agreement. Decide early who will be the records custodian after closing, particularly if the physician entity is changing hands, and confirm what your state requires on notice to patients and retention periods.

The Financial File a Med Spa Buyer Rebuilds

Every buyer will rebuild your earnings in a quality of earnings review. Med spas have a few accounting features that cause most of the adjustments, and you can get ahead of all of them.

Prepaid packages, memberships and gift cards

Cash collected for services not yet delivered is a liability, not revenue. If your books record a twelve-session laser package as revenue on the day it is sold, a buyer will move the unearned portion into deferred revenue, lowering the earnings you are paid on, and may treat the balance as a debt-like item that reduces the purchase price at closing. The fix is to move to accrual accounting and track deferred revenue by source: packages, memberships with banked credits, gift cards and any loyalty balances you honor.

Membership data that proves recurring revenue

Buyers pay more for revenue they can predict. A membership program is the clearest evidence, but only if you can show it with data: active members by month, cancellations, plan mix, average monthly revenue per member and how often members visit compared with non-members. Pull this from your booking or practice management system for at least the last few years.

Revenue by service line and provider

Report revenue and visits separately for neurotoxins, fillers, lasers and devices, skin treatments, weight loss, IV therapy, retail and memberships, and show the split by provider. This exhibit answers most of a buyer’s early questions about margin, concentration and repeat behavior.

Devices and leases

Build a schedule of every laser and energy device with purchase date, cost, financing or lease terms, monthly payments, remaining balance and service contract status. Leased or financed devices are usually treated as debt at closing. Devices near the end of their useful life signal capital spending the buyer will price in.

Working capital and the closing balance sheet

Most purchase agreements include a working capital target. If the business delivers less working capital at closing than the target, the price drops; if it delivers more, the price rises. In a med spa, the items that move this calculation are inventory (toxins, fillers and retail stock), receivables from financing companies and card processors, accrued payroll and commissions, and deferred revenue. Avoid stocking up on product just before closing to reach a supplier rebate tier, and avoid running inventory down to boost cash. Buyers will usually set the target from an average over the trailing twelve months, so steady habits in the year before a sale make the negotiation simpler.

Owner add-backs

List every expense you believe a new owner would not incur, with the invoice behind it: personal costs run through the business, above-market owner pay, one-time legal costs for a restructuring, related-party rent above market. Buyers accept documented, reasonable adjustments and reject vague ones, and an aggressive add-back list makes them doubt everything else.

Real estate

If you own the building, decide before going to market whether it is part of the sale. Many buyers prefer to lease rather than own clinic real estate. Holding the property in a separate entity with a written lease at market rent keeps the operating business clean and lets you sell the property separately or keep it as an income asset. If you rent from a related party at a rent above or below market, expect the buyer to adjust earnings to a market figure.

Any insurance billing

Most med spas are cash-pay, but some bill insurance for medical services such as treatment of excessive sweating or medical weight management. Any payer billing brings coding, documentation and payer contract rules into scope. If you bill insurance, keep that revenue separate in your reports, document coding practices and be ready for a buyer to review a sample of claims.

Taxes on retail and services

Retail skincare is taxable in most states, and some states tax certain services. Check that you have been collecting and remitting correctly, because a buyer’s tax review will look back several years.

Med Spa Data Room Checklist

Use this as a starting list. Most of it can be prepared a year or more before a sale and refreshed each quarter.

Board Complaints, Claims and the Clinical History

Buyers search state board records for the medical director, any supervising physicians and every licensed provider, and they ask for malpractice claim history and the adverse event log. A single resolved complaint is rarely a problem if it is disclosed and the follow-up is documented. A pattern in one treatment category, such as repeated filler complications, raises questions about training and supervision that a buyer will try to price.

Prepare a short schedule of every complaint, claim and significant adverse event in the last several years, with dates, outcome and what changed afterwards. Confirm that your malpractice coverage is current for every provider and understand whether it is written on a claims-made or occurrence basis, since that determines whether tail coverage is needed at closing. Check that every provider’s license lookup matches what you report, including names, license types and expiry dates.

Booking, Charting and Data Systems

Platforms usually move acquired clinics onto their own booking, charting and payment systems after closing. Before that happens, a buyer wants to know that your data is complete and can be exported: patient records with treatment history and photos, membership and package balances, gift card liabilities, and provider schedules. Messy data slows integration and makes buyers doubt the reports you have given them.

Ahead of a sale, confirm that charts are completed and signed in your system rather than on paper, that membership and package balances in the booking system match the deferred revenue in your books, and that you own your data under your software contracts. Check the notice period and any termination fees for each system, because the buyer will ask what it costs to switch.

Your Own Role After Closing

Many med spa buyers want the founder to stay for a period, especially if the founder is also a provider with a loyal patient following. Decide what you want before the first conversation, because it shapes the structure of every offer.

• Clinical role. If you inject, how many days a week will you keep working, for how long, and on what pay?
• Leadership role. Will you run the clinic, sit on a regional leadership team, or step back to an advisory role?
• Restrictive covenants. Sellers are usually asked to agree not to compete or solicit patients and staff for a period after the sale. These terms are negotiated in the purchase agreement and treated differently from employee non-competes in many states, so have counsel review the scope, length and geography.
• Link to earnouts. If part of your price depends on post-closing performance, make sure your role gives you enough influence over the results you are being measured on.

What Buyers Request Before a Letter of Intent

Serious buyers will not commit to a price without a first look at a focused set of documents. Having these ready, accurate and consistent with each other shortens the time to an offer and signals that confirmatory diligence will go smoothly.

1. Monthly income statements for the last two to three years and the trailing twelve months. Buyers want trends and seasonality, and they will compare monthly figures with your tax returns.
2. A current balance sheet with deferred revenue shown separately. This starts the working capital and debt-like items discussion.
3. An adjusted earnings bridge. Each add-back with a one-line explanation and the support behind it.
4. Revenue and visits by service line, provider and month. The single most useful exhibit for a med spa buyer.
5. Membership data. Active members, new joins, cancellations, plan mix and member spend over time.
6. An anonymized staff roster. Role, license type, start date, pay structure, employment classification and agreement status.
7. The ownership and management structure. An organization chart showing the physician entity, the management company and the agreements between them.
8. The device and lease schedule. Every device with financing terms, and the premises lease with assignment provisions.
9. A compliance summary. Board complaints, adverse events, product sourcing and marketing practices, described briefly and honestly.
10. A simple forward plan. Where growth will come from over the next few years: providers, rooms, services, locations or pricing.

Owners often hold back bad news until later in the process. In this sector that tends to backfire, because buyers expect to find something and assume the worst when they find it late. Disclosing a known issue early, with the fix already under way, usually costs less than having it found.

Confirmatory Diligence: What Happens After the LOI

Once you sign a letter of intent, the buyer gets an exclusive period to finish its review. In a med spa deal, expect several workstreams to run at the same time:

1. Accounting. A quality of earnings firm tests revenue timing, deferred revenue, add-backs and working capital.
2. Healthcare regulatory. Counsel reviews the ownership structure, management agreement, delegation protocols, licenses and any board complaints.
3. Clinical. A clinical reviewer may sample charts, consents and adverse event records.
4. Product and pharmacy. Purchase records for toxins, fillers and compounded drugs are matched to suppliers.
5. Employment. Provider agreements, classification, pay practices and benefits are reviewed.
6. Marketing. Influencer agreements, disclosures and review practices are checked against FTC guidance.
7. Real estate and equipment. Lease assignment, landlord consent and device financing are confirmed.
8. Systems. The buyer checks whether your booking and charting systems can migrate to its platform.

Each workstream produces findings that can turn into price adjustments or special indemnities. The work in the earlier sections is how you keep that list short.

Commissioning Your Own Quality of Earnings Review

A sell-side quality of earnings review is an independent accounting analysis you pay for before going to market. For a med spa it earns its cost in three ways. It forces the deferred revenue question into the open on your timetable, so you can present the adjusted number rather than defend against a buyer’s. It tests your add-backs against the standard a buyer’s accountants will use. And it gives buyers a document they can rely on early, which tends to produce firmer offers and fewer surprises later.

The review is also a rehearsal. Your bookkeeper and practice manager will field the same questions a buyer will ask later, about how revenue is recognized, how commissions are calculated and how inventory is counted, and any weak spots in your process will show up while you still have time to fix them.

Choose a firm with healthcare and aesthetics experience, since the issues that matter most here, such as packages, memberships and the split between the physician entity and the management company, are not the same as in a typical service business. Start the review once you have at least a year of clean accrual-basis monthly statements.

If You Operate More Than One Location

A group of clinics is a different sale from a single site. Buyers will want results by location, not just a combined total, so they can see which clinics carry the group and which are still ramping up. They will also check whether each location has its own physician coverage, supervision records and provider licenses in order, and, if you operate in more than one state, whether the ownership structure works in each of them. A structure that is fine in one state can be a problem in a neighboring one.

New locations opened in the last year or two need special care. Buyers often value a young clinic on what it earns today rather than on your projection, so present its ramp-up honestly, with monthly visits, revenue and break-even timing. If you plan further openings, show the pipeline with signed leases and budgets, and be clear about which openings are committed. A credible expansion plan can support a higher valuation, while an optimistic one invites a buyer to tie part of the price to results.

Shared costs deserve attention too. If a central team handles marketing, purchasing or bookkeeping for all clinics, show how those costs are allocated, so a buyer can judge what each location really earns and what the group would cost to run inside a larger platform.

Issues That Cause Med Spa Deals to Be Re-Priced

These are the findings that most often turn a good letter of intent into a worse final agreement. All of them are cheaper to fix before a sale than during one.

1. A lay-owned company with a hired medical director in a strict state. The California Medical Board’s own example describes this arrangement as involving non-physicians in unlicensed practice.
2. Clinical decisions made by the management company. Equipment choices, provider hiring and chart ownership sitting with the lay entity.
3. Toxin or filler purchases outside authorized channels. The FDA’s 2024 counterfeit warning made this a standard diligence check.
4. Undocumented delegation. Missing protocols, exams or chart reviews for delegated treatments.
5. IV or weight-loss services launched without updated protocols. Texas House Bill 3749 is a reminder that states are writing new rules for these services.
6. Prepaid services booked as revenue on sale. Deferred revenue adjustments cut earnings and can reduce cash at closing.
7. A single provider carrying the practice. Expect a larger earnout or holdback tied to that person.
8. Influencer posts without proper disclosure, or incentivized reviews. Both are addressed directly in FTC guidance and the 2024 reviews rule.
9. Contractor classification for clinical staff. Raises payroll tax exposure and questions about supervision.
10. Uncollected sales tax on retail. Look-back exposure becomes a specific indemnity.
11. Open board complaints or adverse events without follow-up records. Buyers cannot size a risk they cannot see.
12. A premises lease that cannot be assigned without landlord consent. Consent should be requested early, not in the last week before closing.

Full Sale or Partnership: Testing the Rollover Equity Terms

Because so many med spa deals include rollover, the terms of that equity deserve as much attention as the cash price. Before you accept a structure with a large rollover component, get clear answers to these questions:

• What exactly will you own? Units in the platform’s holding company, in an intermediate entity or in your own clinic? Equity higher up the structure is more diversified; equity in your own clinic ties you to one location.
• How is it valued? Is your rollover priced at the same value per unit the sponsor paid, or at a different figure?
• What debt sits ahead of you? Platform borrowing is repaid before equity holders see anything in a sale.
• What happens if you leave? Many agreements let the company buy back a departing founder’s equity, sometimes at a discount if you leave early or for cause.
• What rights come with it? Information rights, a right to sell alongside the sponsor when it exits, and protection against dilution when new capital comes in.
• When do you get paid? Most rollover pays out only when the platform is sold or recapitalized, so ask about the sponsor’s expected holding period.

AmSpa’s naming of several platforms as recapitalization candidates for 2026 and 2027 is a reminder that rollover can pay well when the platform performs. It is still a minority stake in a business you do not control, and it should be weighed that way against an offer with more cash and less upside.

A 36-Month Med Spa Exit Calendar

Plan a med spa sale three years ahead: settle the ownership structure and physician supervision records first, then spread patients across providers and build membership data, then move to accrual books with a deferred revenue schedule. Use the final year for a sell-side quality of earnings review and a confidential approach to a short list of buyers.

36 months out: structure and compliance

• Get a written opinion from healthcare counsel on your ownership structure and management agreement in each state where you operate, and restructure if needed.
• Write or update delegation protocols for every treatment category, including IV therapy and weight-loss prescribing.
• Move all toxin and filler purchasing to manufacturer or authorized distributor channels and keep invoices tied to lot numbers.
• Switch to accrual accounting and start tracking deferred revenue by source.
• Review provider classification and agreements with employment counsel.
• Audit influencer disclosures and your review request process against FTC guidance.

24 months out: people and recurring revenue

• Hire or promote a practice manager so daily operations do not depend on the owner.
• Spread patient panels across providers and reduce the share of revenue tied to any one injector, including the owner.
• Launch or rework a membership program and start reporting member counts and cancellations monthly.
• Close the books monthly with revenue reported by service line and provider.
• Start a running list of owner add-backs with supporting invoices.

12 months out: proof

• Commission a sell-side quality of earnings review.
• Prepare the device schedule, lease summary and landlord consent requirements.
• Separate weight-loss revenue by product type and document the pharmacy relationships.
• Assemble the supervision records, adverse event log and consent forms in one place.
• Decide whether you want a full sale or a partnership with rollover equity, and what role you want after closing.

6 months out: materials

• Engage an M&A advisor and agree the buyer list, including platforms that fit your state and service mix.
• Prepare a confidential information memorandum and a short anonymous teaser.
• Populate the data room using the checklist above.
• Rehearse the management presentation with your practice manager and lead providers.

3 months out: the process

• Approach buyers confidentially and collect indications of interest.
• Hold management meetings with the most credible buyers.
• Compare letters of intent on cash at closing, rollover terms, earnouts, holdbacks and post-closing role, not only on headline value.
• Sign with one buyer and support confirmatory diligence until closing.

Selling Your Med Spa in Less Than a Year

Health, a partnership dispute, a move or an unexpected offer can shorten the timeline. A sale inside a year is still possible if you concentrate on what a buyer cannot ignore.

• Confirm the legal structure. Have counsel review ownership and the management agreement against your state’s rules before any buyer sees them.
• Put supervision on paper. Collect delegation protocols, the medical director agreement and chart review records into one file.
• Check product invoices. Be ready to show that toxins and fillers came from authorized sources.
• Secure your providers. Make sure each injector has a written agreement and talk to your lead providers about the transition before buyers do.
• Separate prepaid revenue. Even a rough deferred revenue schedule is better than none.
• List devices and leases. Know every balance and whether your premises lease can be assigned.

A faster process usually means a smaller buyer pool and more of the price tied to retention or performance after closing. For the mechanics of a live sale, see our guide on how to sell a medspa.

Keeping the Process Confidential With Staff and Patients

News of a sale can unsettle providers and invite competitors to approach them, which is exactly the risk buyers are trying to price. Keep the circle small. Share the plan with your practice manager and, at the right point, your lead providers, ideally with retention arrangements ready to discuss. Use anonymous descriptions with buyers until they sign a confidentiality agreement, and schedule site visits outside patient hours. Agree with the buyer in advance how and when staff and patients will be told, and what will stay the same for them, such as location, providers and membership terms. A calm, planned announcement protects the patient base you are being paid for.

How CT Acquisitions Runs a Med Spa Sale

CT Acquisitions is an M&A advisory firm for founder-owned businesses, working on the sell side, the buy side and exit planning, with a network of 500+. For med spa owners we start with a readiness review against the items on this page, so you know what a buyer would find before one looks. When you are ready, we prepare the materials, approach a targeted group of platforms and other buyers confidentially, and help you compare offers on what matters to you: cash at closing, the value and rights of any rollover, earnout terms, and your role afterwards. We stay involved through confirmatory diligence and closing.

Frequently Asked Questions

How long should I plan for before selling my medical spa to a private equity buyer?

The owners who get top-quartile pricing start preparing 24 to 36 months before going to market. The minimum useful prep window is 12 months, because most of the high-leverage levers (lifting membership penetration from 14% to 30%+, installing a GM, getting on a modern medspa EMR, restructuring the MSO/PC and medical director arrangement, reclassifying 1099 clinical staff to W-2, running a sell-side QoE) need 12+ months of clean trailing-twelve-months data to be credible to a buyer. Owners who try to sell in under 6 months typically leave 20% to 40% of enterprise value on the table.

What is a realistic EBITDA multiple for a $2M EBITDA medical spa in 2026?

For a $2M EBITDA medspa in 2026, the range is 5x to 8x at the single- or two-location tier with 15%+ growth and a real management layer (Scope Research 2025; Breakwater M&A 2026). The bottom of that range applies to single-location, owner-injector-dependent shops with under 14% membership penetration, weak compliance documentation, and concentrated provider risk. The top applies to multi-provider, multi-location, 30%+ membership penetration, documented MSO/PC structure, GM in place, modern medspa EMR. Cross-vertical tie-ins to dermatology or plastic surgery can push toward the 7x to 9x platform-quality range (Breakwater M&A 2026; FOCUS Investment Banking 2026). At $20M+ revenue with brand equity and recurring base, the range shifts to 7x to 12x (Scope Research 2025; FOCUS Bankers 2026). The 36-month prep playbook is what moves you from the bottom of the band to the top.

What percentage of membership revenue do PE buyers want to see?

30% or higher is the threshold that moves your business into the premium pricing tier per FOCUS Investment Banking 2026 and Breakwater M&A’s “recurring revenue + 15%+ growth” criterion. Industry-average membership penetration sits at 14% (Pabau 2025; Vagaro 2026), so getting to 30% requires a deliberate 18 to 24 month membership-conversion program. Members visit 2.9x more often, spend 35% more per visit, and represent 4.8x more lifetime value than per-visit clients (ProSpyrMed 2025; Boulevard “Average Med Spa Revenue” 2025). On a $1.5M EBITDA medspa, getting to 30%+ recurring is worth 0.5x to 1.0x in multiple uplift, or $750K to $1.5M of additional sale price (FOCUS Bankers 2026).

Should I get a quality of earnings report done before going to market?

For medical spas at $1M+ EBITDA, yes. A sell-side QoE costs $40K to $90K typical for a medspa with multiple service lines, a membership program, deferred revenue, and an MSO/PC structure (Eton Venture Services 2025; Ankura Transaction Advisory 2025), up to $150K to $200K for complex multi-state structures. The ROI is leverage. If your QoE supports a 1x multiple uplift on a $3M EBITDA medspa at a 5x baseline, that is $3M of additional sale price for a $60K to $90K investment, a 33x to 50x return. More importantly, a pre-market QoE surfaces deferred revenue treatment, medical director fee FMV, and owner-injector compensation normalization while you can still fix them, rather than during exclusivity when the buyer re-trades the deal.

Will private equity keep my injectors and providers after they buy my practice?

Yes, with conditions. Provider retention is the chassis of medspa value, and buyers structure transactions to lock providers in. Most 2025 medspa transactions were structured as 60% cash at close + 40% rollover equity, ranging up to 80% cash + 20% rollover, with holdbacks and earnouts tied directly to provider retention (AmSpa “Med Spa M&A and Private Sales: A Look Back at 2025”). The common buyer response to single-injector concentration above 30% is a 12 to 24 month earn-out tied to that provider staying plus rollover equity in the platform. If key providers walk during confirmatory diligence or immediately post-acquisition, the buyer either re-trades the deal heavily or terminates entirely (NERO 2026). The work to do pre-sale is bring in 2 to 3 W-2 injectors 18+ months before going to market and cross-pollinate patient panels so no single provider holds 30%+ of injectable revenue.

What is the medical director arrangement that buyers require?

Buyers require a documented MSO/PC structure with a written medical director agreement, written delegation protocols for every procedure category, a documented chart sign-off cadence, and a medical director fee at fair market value (typically $30K to $80K annually, with a written FMV opinion on file). In CPOM-restrictive states (CA, NY, TX, and others) the physician must own the PC; the non-physician owns the MSO; the MSO management fee must be fixed or cost-plus (percentage-of-revenue fees are allowed in some states but banned in others) (Cohen Healthcare Law; Permit Health 50-State CPOM Guide; Guardian Medical Direction). NY State has begun explicit crackdowns on “paper medical directors” who lend names without active oversight, with surprise inspections (Norman Spencer Law Group “Med Spas Under Fire” 2025). TX, effective Sept 1, 2025 via HB 3749, requires every medspa to appoint a medical director with specific training (McGuireWoods 2025). NERO 2026 calls compliance “the new deal-killer” and Hinshaw & Culbertson 2025 explicitly state: “Issues in any of these areas do not just reduce your multiple, they can cause buyers to walk away entirely.”

Can I sell my med spa if I am not a physician?

Usually yes, but the structure matters. Many states restrict non-physician ownership of medical practices, so med spas in those states often run through a management services organization that contracts with a physician-owned professional corporation. A buyer will check that this structure is compliant before closing. Have healthcare counsel review your setup early, because fixing it during diligence costs time and price.

How much can I sell my med spa for?

It depends on earnings, size and how dependent the practice is on you. Buyers start from normalized EBITDA, or SDE for smaller owner-run spas, and apply a multiple that rises with membership revenue, provider depth, multiple locations and a clean CPOM structure. The multiple ranges and recent transactions earlier in this guide show where your spa might sit; a buyer-specific read narrows it further.

What to Do Next

The medical spa owners who get the top-quartile multiple all do the same three things. They start preparing 24 to 36 months before they want to be out. They get the MSO/PC structure and medical director arrangement bulletproof in every operating state before a buyer ever sees a CIM. And they bring in 2 to 3 W-2 injectors plus a GM 18+ months pre-sale so provider concentration is no longer a flight risk by the time confirmatory diligence starts.

Medical spa is one of the most active healthcare-services PE lanes right now because it is cash-pay (no insurance billing friction), membership-recurring (the Alle Skincare Society loyalty model and custom in-house memberships compound retention), and high gross margin (injectables carry high gross margins). Platform-quality medspas trade at 7x to 9x EBITDA per Breakwater M&A, and scaled operators with a dermatology or plastics tie-in reach 10x to 12x per FOCUS Investment Banking. Recent activity shows the capital at work: Princeton Medspa Partners bought Allura Skin in December 2025, Alpha Aesthetics Partners closed a $93M financing led by Manulife Investment Management in January 2026 (PR Newswire), AMP rebranded 12 clinics as Avelure in May 2026, and Hidden Harbor and Carlyle AlpInvest closed an $850M continuation fund that includes Inspire Aesthetics in May 2025 (Hidden Harbor press release). The capital is there. The question is whether your business is in shape to capture the top of the multiple band when you go to market.

If you are 12+ months from a potential exit and want a structured pre-sale optimization roadmap, CT Acquisitions has aesthetics operations specialists in our partner network who run multi-quarter prep engagements. If you are 6 to 12 months out and ready to start the sell-side process, our M&A advisory team runs the buyer outreach. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing. Either way, the first 30 minutes are free.